Table 2.
Group | ID | Days post-inoculation (DPI)a | |||
---|---|---|---|---|---|
0 | 2 | 5 | 10 | ||
IDV+ MHA+ | 26 | <1:10 | <1:10 | <1:10 | 1:320 |
33 | <1:10 | <1:10 | <1:10b | 1:213.33 | |
50 | <1:10 | <1:10 | <1:10 | 1:160 | |
55 | <1:10 | <1:10b | <1:10 | 1:13.33 | |
IDV− MHA+ | 28 | <1:10 | <1:10 | <1:10 | <1:10 |
30 | <1:10 | <1:10 | <1:10 | <1:10 | |
38 | <1:10 | <1:10 | <1:10 | <1:10 | |
57 | <1:10 | <1:10 | <1:10 | <1:10 | |
IDV+ MHA− | 27 | <1:10 | <1:10 | <1:10b | 1:213.33 |
31 | <1:10 | <1:10 | <1:10 | 1:266.67 | |
51 | <1:10 | <1:10 | <1:10 | 1:106.67 | |
52 | <1:10 | <1:10 | <1:10 | 1:80 | |
IDV− MHA− | 29 | <1:10 | <1:10 | <1:10 | <1:10 |
32 | <1:10 | <1:10 | <1:10 | <1:10 | |
35 | <1:10 | <1:10 | <110 | <1:10 | |
56 | <1:10 | <1:10 | <1:10 | <1:10 |